LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 382

Search options

  1. Article: Chaotic breathing in post-COVID-19 breathlessness: a key feature of dysfunctional breathing can be characterised objectively by approximate entropy.

    Samaranayake, Chinthaka B / Warren, Christopher / Rhamie, Serena / Haji, Gulam / Wort, S John / Price, Laura C / McCabe, Colm / Hull, James H

    ERJ open research

    2023  Volume 9, Issue 4

    Abstract: Post-COVID-19 breathing pattern disorder can be characterised by application of nonlinear statistical modelling of exercise ventilatory ... ...

    Abstract Post-COVID-19 breathing pattern disorder can be characterised by application of nonlinear statistical modelling of exercise ventilatory data
    Language English
    Publishing date 2023-07-17
    Publishing country England
    Document type Journal Article
    ZDB-ID 2827830-6
    ISSN 2312-0541
    ISSN 2312-0541
    DOI 10.1183/23120541.00117-2023
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Pulmonary hypertension in ARDS: inflammation matters!

    Price, Laura C / Wort, S John

    Thorax

    2017  Volume 72, Issue 5, Page(s) 396–397

    Language English
    Publishing date 2017-05
    Publishing country England
    Document type Editorial
    ZDB-ID 204353-1
    ISSN 1468-3296 ; 0040-6376
    ISSN (online) 1468-3296
    ISSN 0040-6376
    DOI 10.1136/thoraxjnl-2016-209199
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Pulmonary vasodilator treatment in pulmonary hypertension due to left heart or lung disease: time for a high-definition picture?

    Piccari, Lucilla / Bernardo, Roberto J / Rodríguez-Chiaradía, Diego / Vitulo, Patrizio / Wort, S John / Sahay, Sandeep

    Pulmonary circulation

    2021  Volume 11, Issue 2, Page(s) 20458940211018074

    Language English
    Publishing date 2021-05-29
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2638089-4
    ISSN 2045-8940 ; 2045-8932
    ISSN (online) 2045-8940
    ISSN 2045-8932
    DOI 10.1177/20458940211018074
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Earlier diagnosis and international registries may improve outcomes in pulmonary tumour thrombotic microangiopathy.

    Price, Laura C / Wort, S John

    The European respiratory journal

    2016  Volume 47, Issue 2, Page(s) 690–691

    MeSH term(s) Female ; Humans ; Hypertension, Pulmonary/diagnosis ; Lung Neoplasms/diagnosis ; Male ; Thrombotic Microangiopathies/diagnosis
    Language English
    Publishing date 2016-02
    Publishing country England
    Document type Comment ; Letter
    ZDB-ID 639359-7
    ISSN 1399-3003 ; 0903-1936
    ISSN (online) 1399-3003
    ISSN 0903-1936
    DOI 10.1183/13993003.01736-2015
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Sendaway capillary NT-proBNP in pulmonary hypertension.

    Stubbs, Harrison D / Cannon, John / Knightbridge, Emily / Durrington, Charlotte / Roddis, Chloe / Gin-Sing, Wendy / Massey, Fiona / Knight, Daniel S / Virsinskaite, Ruta / Lordan, James L / Sear, Eleanor / Apple-Pinguel, Joy / Morris, Eleanor / Johnson, Martin K / Wort, Stephen J

    BMJ open respiratory research

    2024  Volume 11, Issue 1

    Abstract: Background: N-terminal pro-B-type natriuretic peptide (NT-proBNP) is a biomarker of cardiac ventricular wall stress that is incorporated into pulmonary hypertension (PH) risk stratification models. Sendaway sampling may enable patients to perform NT- ... ...

    Abstract Background: N-terminal pro-B-type natriuretic peptide (NT-proBNP) is a biomarker of cardiac ventricular wall stress that is incorporated into pulmonary hypertension (PH) risk stratification models. Sendaway sampling may enable patients to perform NT-proBNP tests remotely. This UK-wide study aimed to assess the agreement of sendaway NT-proBNP with standard venous NT-proBNP and to assess the effect of delayed processing.
    Methods: Reference venous NT-proBNP was collected from PH patients. Samples for capillary and venous sendaway tests were collected contemporaneously, mailed to a reference laboratory and processed at 3 and 7 days using a Roche Cobas e411 device. Differences in paired measurements were analysed with Passing-Bablok regression, percentage difference plots and the % difference in risk strata.
    Results: 113 patients were included in the study. 13% of day 3 capillary samples were insufficient. Day 3 capillary samples were not equivalent to reference samples (Passing Bablok analysis slope of 0.91 (95% CI 0.88 to 0.93) and intercept of 6.0 (95% CI 0.2 to 15.9)). The relative median difference was -7% and there were acceptable limits of agreement. Day 3 capillary NT-proBNP accurately risk stratified patients in 93.5% of cases. By comparison, day 3 venous results accurately risk stratified patients in 90.1% of cases and were equivalent by Passing-Bablok regression. Delayed sampling of sendaway tests led to an unacceptable level of agreement and systematically underestimated NT-proBNP.
    Conclusions: Sendaway NT-proBNP sampling may provide an objective measure of right ventricular strain for virtual PH clinics. Results must be interpreted with caution in cases of delayed sampling.
    MeSH term(s) Humans ; Natriuretic Peptide, Brain ; Hypertension, Pulmonary/diagnosis ; Peptide Fragments ; Biomarkers
    Chemical Substances pro-brain natriuretic peptide (1-76) ; Natriuretic Peptide, Brain (114471-18-0) ; Peptide Fragments ; Biomarkers
    Language English
    Publishing date 2024-03-22
    Publishing country England
    Document type Journal Article
    ZDB-ID 2736454-9
    ISSN 2052-4439 ; 2052-4439
    ISSN (online) 2052-4439
    ISSN 2052-4439
    DOI 10.1136/bmjresp-2023-002124
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Use of pulmonary arterial hypertension therapies in patient swith sarcoidosis-associated pulmonary hypertension.

    Price, Laura C / Kouranos, Vaileios / Baughman, Robert / Bloom, Chloe / Stewart, Iain / Shlobin, Oksana / Nathan, Steven / Dimopoulos, Konstantinos / Falconer, Jonathan / Gupta, Rohit / McCabe, Colm / Samaranayake, Chinthaka / Mason, Thomas / Mukherjee, Bhashkhar / Taube, Catherine / Sahni, Ankita / Kempny, Aleksander / Semple, Thomas / Renzoni, Elizabetta /
    Wells, Athol / Wort, S John

    Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG

    2024  Volume 41, Issue 1, Page(s) e2024024

    Language English
    Publishing date 2024-03-26
    Publishing country Italy
    Document type Journal Article
    ZDB-ID 1339192-6
    ISSN 2532-179X ; 1124-0490
    ISSN (online) 2532-179X
    ISSN 1124-0490
    DOI 10.36141/svdld.v41i1.15515
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Right ventricular functional recovery assessment with stress echocardiography and cardiopulmonary exercise testing after pulmonary embolism: a pilot prospective multicentre study.

    Samaranayake, Chinthaka Bhagya / Upham, John / Tran, Khoa / Howard, Luke S / Nguyen, Sean / Lwin, Myo / Anderson, James / Wahi, Sudhir / Price, Laura C / Wort, Stephen / Li, Wei / McCabe, Colm / Keir, Gregory J

    BMJ open respiratory research

    2023  Volume 10, Issue 1

    Abstract: Background: Data on right ventricular (RV) exercise adaptation following acute intermediate and high-risk pulmonary embolism (PE) remain limited. This study aimed to evaluate the symptom burden, RV functional recovery during exercise and cardiopulmonary ...

    Abstract Background: Data on right ventricular (RV) exercise adaptation following acute intermediate and high-risk pulmonary embolism (PE) remain limited. This study aimed to evaluate the symptom burden, RV functional recovery during exercise and cardiopulmonary exercise parameters in survivors of intermediate and high-risk acute PE.
    Methods: We prospectively recruited patients following acute intermediate and high-risk PE at four sites in Australia and UK. Study assessments included stress echocardiography, cardiopulmonary exercise testing (CPET) and ventilation-perfusion (VQ) scan at 3 months follow-up.
    Results: Thirty patients were recruited and 24 (median age: 55 years, IQR: 22) completed follow-up. Reduced peak oxygen consumption (VO
    Conclusion: In our cohort, impaired RV adaptation on exercise was seen in almost one-third of patients. Combined stress echocardiography and CPET may enable more accurate phenotyping of patients with persistent symptoms following acute PE to allow timely detection of long-term complications.
    MeSH term(s) Humans ; Middle Aged ; Echocardiography, Stress ; Exercise Test ; Prospective Studies ; Quality of Life ; Pulmonary Embolism/diagnostic imaging ; Oxygen
    Chemical Substances Oxygen (S88TT14065)
    Language English
    Publishing date 2023-07-04
    Publishing country England
    Document type Multicenter Study ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2736454-9
    ISSN 2052-4439 ; 2052-4439
    ISSN (online) 2052-4439
    ISSN 2052-4439
    DOI 10.1136/bmjresp-2023-001637
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Tumoral pulmonary hypertension.

    Price, Laura C / Seckl, Michael J / Dorfmüller, Peter / Wort, S John

    European respiratory review : an official journal of the European Respiratory Society

    2019  Volume 28, Issue 151

    Abstract: Tumoral pulmonary hypertension (PH) comprises a variety of subtypes in patients with a current or previous malignancy. Tumoral PH principally includes the tumour-related pulmonary microvascular conditions pulmonary tumour microembolism and pulmonary ... ...

    Abstract Tumoral pulmonary hypertension (PH) comprises a variety of subtypes in patients with a current or previous malignancy. Tumoral PH principally includes the tumour-related pulmonary microvascular conditions pulmonary tumour microembolism and pulmonary tumour thrombotic microangiopathy. These inter-related conditions are frequently found in
    MeSH term(s) Animals ; Antineoplastic Agents/adverse effects ; Arterial Pressure ; Humans ; Hydrogen-Ion Concentration ; Hypertension, Pulmonary/chemically induced ; Hypertension, Pulmonary/epidemiology ; Hypertension, Pulmonary/pathology ; Hypertension, Pulmonary/physiopathology ; Molecular Targeted Therapy/adverse effects ; Neoplasms/drug therapy ; Neoplasms/epidemiology ; Neoplasms/pathology ; Neoplastic Cells, Circulating/drug effects ; Neoplastic Cells, Circulating/pathology ; Prognosis ; Pulmonary Artery/drug effects ; Pulmonary Artery/pathology ; Pulmonary Artery/physiopathology ; Risk Assessment ; Risk Factors ; Tumor Microenvironment
    Chemical Substances Antineoplastic Agents
    Language English
    Publishing date 2019-02-06
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 1077620-5
    ISSN 1600-0617 ; 0905-9180
    ISSN (online) 1600-0617
    ISSN 0905-9180
    DOI 10.1183/16000617.0065-2018
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Covid-19 pneumonia and pulmonary vascular disease: A UK Centre perspective.

    John Wort, S / Arachchillage, D J / McCabe, C / Price, L C

    Respiratory medicine and research

    2020  Volume 78, Page(s) 100781

    MeSH term(s) COVID-19/complications ; COVID-19/epidemiology ; COVID-19/therapy ; Critical Care/methods ; Critical Care/standards ; Extracorporeal Membrane Oxygenation/methods ; Extracorporeal Membrane Oxygenation/standards ; Humans ; Hypertension, Pulmonary/epidemiology ; Hypertension, Pulmonary/therapy ; Hypertension, Pulmonary/virology ; Lung Diseases/epidemiology ; Lung Diseases/therapy ; Lung Diseases/virology ; Pandemics ; Pneumonia, Viral/complications ; Pneumonia, Viral/epidemiology ; Pneumonia, Viral/therapy ; Practice Guidelines as Topic ; Pulmonary Embolism/epidemiology ; Pulmonary Embolism/therapy ; Pulmonary Embolism/virology ; Pulmonary Veno-Occlusive Disease/epidemiology ; Pulmonary Veno-Occlusive Disease/etiology ; Pulmonary Veno-Occlusive Disease/therapy ; SARS-CoV-2/physiology ; United Kingdom/epidemiology ; Vascular Diseases/epidemiology ; Vascular Diseases/therapy ; Vascular Diseases/virology
    Keywords covid19
    Language English
    Publishing date 2020-08-03
    Publishing country France
    Document type Editorial
    ISSN 2590-0412
    ISSN (online) 2590-0412
    DOI 10.1016/j.resmer.2020.100781
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Differential responses of pulmonary vascular cells from PAH patients and controls to TNFα and the effect of the BET inhibitor JQ1.

    Mumby, Sharon / Perros, Frederic / Grynblat, Julien / Manaud, Gregoire / Papi, Alberto / Casolari, Paolo / Caramori, Gaetano / Humbert, Marc / John Wort, S / Adcock, Ian M

    Respiratory research

    2023  Volume 24, Issue 1, Page(s) 193

    Abstract: Background: Pulmonary arterial hypertension (PAH) encompasses a group of diseases characterized by raised pulmonary vascular resistance, resulting from vascular remodelling and inflammation. Bromodomain and extra-terminal (BET) proteins are required for ...

    Abstract Background: Pulmonary arterial hypertension (PAH) encompasses a group of diseases characterized by raised pulmonary vascular resistance, resulting from vascular remodelling and inflammation. Bromodomain and extra-terminal (BET) proteins are required for the expression of a subset of NF-κB-induced inflammatory genes which can be inhibited by the BET mimic JQ1+. We hypothesised that JQ+ would supress TNFα-driven inflammatory responses in human pulmonary vascular cells from PAH patients.
    Methods: Immunohistochemical staining of human peripheral lung tissue (N = 14 PAH and N = 12 non-PAH) was performed for the BET proteins BRD2 and 4. Human pulmonary microvascular endothelial cells (HPMEC) and pulmonary artery smooth muscle cells (HPASMC) from PAH patients (N = 4) and non-PAH controls (N = 4) were stimulated with TNFα in presence or absence of JQ1+ or its inactive isomer JQ1-. IL-6 and -8 mRNA was measured by RT-qPCR and protein levels by ELISA. Chromatin immunoprecipitation analysis was performed using EZ-ChIP™ and NF-κB p65 activation determined using a TransAm kit. MTT assay was used to measure cell viability.
    Results: Nuclear staining of BRD2 and BRD4 was significantly (p < 0.0001) increased in the lung vascular endothelial and smooth muscle cells from PAH patients compared to controls with normal lung function. TNFα-driven IL-6 release from both HPMECs and HPASMCs was greater in PAH cells than control cells. Levels of CXCL8/IL-8 protein release was higher in PAH HPASMCs than in control cells with similar release observed in HPMECs. TNFα-induced recruitment of activated NF-κB p65 to the IL-6 and CXCL8/IL-8 promoters were similar in both cell types and between subject groups. JQ1+ suppressed TNFα-induced IL-6 and CXCL8/IL-8 release and mRNA expression to a comparable extent in control and PAH HPMECs and HPASMCs. JQ1 had a greater efficacy on IL-6 release in HPMEC and on CXCL8/IL-8 release in HPASMC.
    Conclusion: BET inhibition decreases TNFα driven inflammation in primary pulmonary vascular cells. The anti-inflammatory actions of JQ1 suggests distinct cell-specific regulatory control of these genes. BET proteins could be a target for future therapies for PAH.
    MeSH term(s) Humans ; Pulmonary Arterial Hypertension ; Tumor Necrosis Factor-alpha ; Interleukin-8 ; Endothelial Cells ; Interleukin-6 ; NF-kappa B ; Nuclear Proteins/genetics ; Transcription Factors/genetics ; Familial Primary Pulmonary Hypertension ; Cell Cycle Proteins
    Chemical Substances Tumor Necrosis Factor-alpha ; Interleukin-8 ; (+)-JQ1 compound ; Interleukin-6 ; NF-kappa B ; Nuclear Proteins ; Transcription Factors ; BRD4 protein, human ; Cell Cycle Proteins
    Language English
    Publishing date 2023-07-29
    Publishing country England
    Document type Journal Article
    ZDB-ID 2041675-1
    ISSN 1465-993X ; 1465-993X
    ISSN (online) 1465-993X
    ISSN 1465-993X
    DOI 10.1186/s12931-023-02499-y
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top